Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
批准号:
6514387
负责人:
Jeffrey T Holt
金额:
$37.35万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2006-05-31
中文摘要
BRCA 2基因是癌症易感基因,其在乳腺癌、前列腺癌、卵巢癌、食道癌和胰腺癌中成熟。作为对这一批评的回应,我们对这一提议进行了显著修改,以研究小鼠BRCA 2缺陷细胞(BRCA 2-)而不是人类BRCA 2缺陷万斯细胞,因为小鼠细胞中的遗传缺陷更简单。我们在小鼠BRCA 2--细胞中的初步数据显示,在BRCA 2缺陷细胞中,Rad 51被caspase-3快速切割,并且BRCA 2或Rad 51的过表达或caspase-3的抑制逆转放射性和DNA修复缺陷。抗半胱天冬酶-3的Rad 51突变体(D-A187 Rad 51)逆转放射敏感性和brca 2中的DNA修复--当两种蛋白质均以接近生理水平表达时,其逆转程度大于野生型Rad 51。我们最近纯化了Rad 51和caspase-3蛋白,以进行体外机制研究。我们目前的新数据显示,Rad 51主要是在brca 2细胞质-,野生型BRCA 2表达重新定位Rad 51的细胞核,而突变体BRCA 2表达不影响Rad 51的本地化。这些发现导致了以下假设:1。BRCA 2通常在双链DNA断裂修复中发挥作用; 2. BRCA 2和Rda 51在介导DNA修复的相同生化途径中起作用; 3. BRCA 2通过抑制caspase-3和其他蛋白酶的降解来稳定Rad 51; 4. BRCA 2影响Rad 51的核定位。为了检验假设,我们提出了这些目标。目的1:确定BRCA 2蛋白介导双链断裂修复和肿瘤发生的功能域。目的2:了解BRCA 2缺陷癌细胞中已知的其他突变是否有助于BRCA 2-细胞中的辐射敏感性和DNA修复缺陷。目的3:通过体外试验确定BRCA 2-Rad 51相互作用的机制和体内意义。目的4:分析BRCA 2-Rad 51的定位机制。目的5:开发和使用体内成像方法来研究Rad 51在活细胞中的定位和DNA修复,在真实的时间。
英文摘要
The BRCA2 gene is a cancer predisposition gene, which is matured in breast cancer, prostate cancer, ovarian cancer, esophageal cancer , and pancreatic cancer. In response to the critique, we have markedly modified this proposal to study mouse BRCA2 defective cells (BRCA2--) instead of human BRCA2 defective Vance cells, since the genetic defect in the mouse cells is simpler. Our preliminary data in mouse BRCA2-- cells shows that Rad51 is rapidly cleaved by caspase-3 in BRCA2 defective cells and that overexpression of BRCA2 or Rad51, or inhibition of caspase-3 reverse radioactivity and the DNA repair defect. A caspase-3 resistant Rad51 mutant (D- A187Rad51) reverses radio sensitivity and the DNA repair in brca2-- to a greater extent than wildtype Rad51 when both proteins are expressed at near physiologic levels. We have recently purified Rad51 and caspase-3 proteins to allow in vitro mechanistic studies. We present new data showing Rad51 is mostly cytoplasmic in brca2--, and that wildtype BRCA2 expression relocates Rad51 to the nucleus whereas mutant BRCA2 expression does not effect Rad51 localization. These fundings lead to the following hypotheses: 1. BRCA2 normally functions in double strand DNA break repair; 2. BRCA2 and Rda51 function in the same biochemical pathway mediating DNA repair; 3. BRCA2 stabilizes Rad51 by inhabiting degradation by caspase-3 and other proteases; 4. BRCA2 influences nuclear localization of Rad51. To test hypothesis we propose these aims. Aim 1: Determine the functional domains of BRCA2 protein which mediate double strand break repair and tumorigenesis. Aim 2: See if known additional mutations in BRCA2 defective cancer cells contribute to radiation sensitivity & DNA repair defects in brca2-- cells. Aim 3: Determine the mechanism and in vivo significance off BRCA2- Rad51 interactions by in vitro assays. Aim 4: Analyze mechanism of BRCA2- Rad51 localization. Aim 5: Develop and use in Vivo imaging methods to study Rad51 localization and DNA repair in living cells, in real time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IHC Test for BRCA1 Hereditary Ovarian Cancer
-
批准号:8239640
-
项目类别:
-
资助金额:$39.92万
-
财政年份:2010
-
负责人:Jeffrey T Holt
-
依托单位:
IHC Test for BRCA1 Hereditary Ovarian Cancer
-
批准号:8259213
-
项目类别:
-
资助金额:$39.92万
-
财政年份:2010
-
负责人:Jeffrey T Holt
-
依托单位:
IHC Test for BRCA1 Hereditary Ovarian Cancer
-
批准号:7804771
-
项目类别:
-
资助金额:$16.36万
-
财政年份:2010
-
负责人:Jeffrey T Holt
-
依托单位:
PARP Inhibitor Targeted Therapy for Breast Cancer
-
批准号:7481522
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2008
-
负责人:Jeffrey T Holt
-
依托单位:
Development of a BRCA Breast Cancer Diagnostic Test
-
批准号:7325640
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2007
-
负责人:Jeffrey T Holt
-
依托单位:
BRCA2 Hereditary Ovarian Cancer Tissue Truncation Test
-
批准号:7404496
-
项目类别:
-
资助金额:$16.17万
-
财政年份:2007
-
负责人:Jeffrey T Holt
-
依托单位:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
-
批准号:6399060
-
项目类别:
-
资助金额:$30.15万
-
财政年份:2001
-
负责人:Jeffrey T Holt
-
依托单位:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
-
批准号:6559526
-
项目类别:
-
资助金额:$3.23万
-
财政年份:2001
-
负责人:Jeffrey T Holt
-
依托单位:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
-
批准号:6608872
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2001
-
负责人:Jeffrey T Holt
-
依托单位:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
-
批准号:6913605
-
项目类别:
-
资助金额:$22.96万
-
财政年份:2001
-
负责人:Jeffrey T Holt
-
依托单位:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
-
批准号:6803434
-
项目类别:
-
资助金额:$23.02万
-
财政年份:2001
-
负责人:Jeffrey T Holt
-
依托单位:
CANCER GENETICS
-
批准号:6103155
-
项目类别:
-
资助金额:$7.03万
-
财政年份:1998
-
负责人:Jeffrey T Holt
-
依托单位:
CORE--VIRAL VECTOR
-
批准号:6103167
-
项目类别:
-
资助金额:$7.03万
-
财政年份:1998
-
负责人:Jeffrey T Holt
-
依托单位:
OVARIAN CANCER GENE THERAPY WITH BRCA1
-
批准号:6115614
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:Jeffrey T Holt
-
依托单位:
CANCER GENETICS
-
批准号:6237633
-
项目类别:
-
资助金额:$6.83万
-
财政年份:1997
-
负责人:Jeffrey T Holt
-
依托单位:
OVARIAN CANCER GENE THERAPY WITH BRCA1
-
批准号:6276848
-
项目类别:
-
资助金额:$3.29万
-
财政年份:1997
-
负责人:Jeffrey T Holt
-
依托单位:
TISSUE TARGETED RETROVIRAL VECTORS IN BREAST CANCER
-
批准号:6246734
-
项目类别:
-
资助金额:$3.1万
-
财政年份:1997
-
负责人:Jeffrey T Holt
-
依托单位:
OVARIAN CANCER GENE THERAPY WITH BRCA1
-
批准号:6246777
-
项目类别:
-
资助金额:$3.1万
-
财政年份:1997
-
负责人:Jeffrey T Holt
-
依托单位:
CORE--VIRAL VECTOR
-
批准号:6237645
-
项目类别:
-
资助金额:$6.83万
-
财政年份:1997
-
负责人:Jeffrey T Holt
-
依托单位:
AFAP-110 as a cSrc activator in breast cancer
-
批准号:8288607
-
项目类别:
-
资助金额:$22.78万
-
财政年份:1994
-
负责人:Jeffrey T Holt
-
依托单位:
海外基金